Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis

Franziska Fischer,Johannes Mücke,Louisa Werny,Katrin Gerrer,Lorenz Mihatsch,Stefanie Zehetmaier,Isa Riedel,Jonas Geisperger,Maren Bodenhausen,Lina Schulte-Hillen,Dieter Hoffmann,Ulrike Protzer,Josef Mautner,Uta Behrends,Tanja Bauer,Nina Körber
DOI: https://doi.org/10.1186/s12985-024-02411-0
IF: 5.916
2024-06-16
Virology Journal
Abstract:Infection with the Epstein-Barr virus (EBV) elicits a complex T-cell response against a broad range of viral proteins. Hence, identifying potential differences in the cellular immune response of patients with different EBV-associated diseases or different courses of the same disorder requires interrogation of a maximum number of EBV antigens. Here, we tested three novel EBV-derived antigen formulations for their ability to reactivate virus-specific T cells ex vivo in patients with EBV-associated infectious mononucleosis (IM).
virology
What problem does this paper attempt to address?